Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
AIDS Care ; 35(8): 1215-1223, 2023 08.
Article in English | MEDLINE | ID: mdl-33745403

ABSTRACT

Chronic pain is a common comorbidity in people with HIV (PWH), with prevalence estimates of 25-85%. Research in this area is growing, but significant gaps remain. A Global Task Force of HIV experts was organized to brainstorm a scientific agenda and identify measurement domains critical to advancing research in this field. Experts were identified through literature searches and snowball sampling. Two online questionnaires were developed by Task Force members. Questionnaire 1 asked participants to identify knowledge gaps in the field of HIV and chronic pain and identify measurement domains in studies of chronic pain in PWH. Responses were ranked in order of importance in Questionnaire 2, which was followed by a group discussion. 29 experts completed Questionnaire 1, 25 completed Questionnaire 2, and 21 participated in the group. Many important clinical and research priorities emerged, including the need to examine etiologies of chronic pain in PWH. Pain-related measurement domains were discussed, with a primary focus on domains that could be assessed in a standardized manner across various cohorts that include PWH in different countries. We collaboratively identified clinical and research priorities, as well as gaps in standardization of measurement domains, that can be used to move the field forward.


Subject(s)
Chronic Pain , HIV Infections , Humans , HIV Infections/complications , HIV Infections/epidemiology , Chronic Pain/epidemiology , Comorbidity
2.
Complement Ther Med ; 59: 102723, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33895267

ABSTRACT

OBJECTIVE: To understand adolescents' experiences and attitudes toward yoga, with a particular focus on acceptability and feasibility of a yoga intervention for depressed adolescents. DESIGN: Qualitative analysis of data from three focus groups and eight individual interviews, for a total of 22 teen participants. SETTING: Outpatient setting in a psychiatric hospital in the U.S. MAIN OUTCOME MEASURES: Teens were asked about their own and their peers' attitudes toward, and experiences with, hatha yoga; reactions to a study-created yoga video; and opinions on class logistics. RESULTS: Teens had both positive and negative attitudes toward, and experiences with, hatha yoga. They commented on "who does yoga;" many responses suggested a limited group (e.g., moms; people with money and time). Participants agreed that yoga could be potentially beneficial for depressed or stressed teens. Self-consciousness while being in a yoga class was a major concern. Overall, teens reacted favorably to the study-created yoga video. Teens had varied opinions about class logistics including class duration and size. Teens cited barriers to class, such as transportation, as well as barriers to home yoga practice. CONCLUSIONS: Key points for developing a yoga class that might be appealing to depressed or stressed teens include: creating a class with variety that teens will find interesting; taking concrete steps to decrease teen self-consciousness; incorporating messages relevant for teens and consistent with yoga philosophy; and actively countering stereotypes about who practices yoga. Limitations of this study include the lack of data from male teens.


Subject(s)
Meditation , Yoga , Adolescent , Attitude , Depression/therapy , Focus Groups , Humans , Male
3.
Psychol Med ; 47(12): 2130-2142, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28382883

ABSTRACT

BACKGROUND: The objective of this study was to determine whether hatha yoga is an efficacious adjunctive intervention for individuals with continued depressive symptoms despite antidepressant treatment. METHOD: We conducted a randomized controlled trial of weekly yoga classes (n = 63) v. health education classes (Healthy Living Workshop; HLW; n = 59) in individuals with elevated depression symptoms and antidepressant medication use. HLW served as an attention-control group. The intervention period was 10 weeks, with follow-up assessments 3 and 6 months afterwards. The primary outcome was depression symptom severity assessed by blind rater at 10 weeks. Secondary outcomes included depression symptoms over the entire intervention and follow-up periods, social and role functioning, general health perceptions, pain, and physical functioning. RESULTS: At 10 weeks, we did not find a statistically significant difference between groups in depression symptoms (b = -0.82, s.e. = 0.88, p = 0.36). However, over the entire intervention and follow-up period, when controlling for baseline, yoga participants showed lower levels of depression than HLW participants (b = -1.38, s.e. = 0.57, p = 0.02). At 6-month follow-up, 51% of yoga participants demonstrated a response (⩾50% reduction in depression symptoms) compared with 31% of HLW participants (odds ratio = 2.31; p = 0.04). Yoga participants showed significantly better social and role functioning and general health perceptions over time. CONCLUSIONS: Although we did not see a difference in depression symptoms at the end of the intervention period, yoga participants showed fewer depression symptoms over the entire follow-up period. Benefits of yoga may accumulate over time.


Subject(s)
Depressive Disorder, Major/rehabilitation , Health Education/methods , Outcome Assessment, Health Care , Yoga , Adult , Antidepressive Agents/therapeutic use , Combined Modality Therapy , Depressive Disorder, Major/drug therapy , Female , Follow-Up Studies , Humans , Male , Middle Aged
4.
Psychol Med ; 43(7): 1465-74, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23137440

ABSTRACT

BACKGROUND: Anxiety disorders are very common and increase risk for suicide attempts. Little is known about predictors of increased risk specifically among individuals with anxiety disorders. The purpose of this study was to investigate whether specific anxiety disorders and other co-morbid psychiatric disorders, physical health, or work or social functioning increased the future likelihood of a suicide attempts among individuals with anxiety disorders. Method In this prospective study, 676 individuals with an anxiety disorder were followed for an average of 12 years. RESULTS: As hypothesized, we found that post-traumatic stress disorder, major depressive disorder (MDD), intermittent depressive disorder (IDD), epilepsy, pain, and poor work and social functioning all predicted a shorter time to a suicide attempt in univariate analyses. In multivariate analyses, baseline MDD and IDD were independent predictors of time to suicide attempt, even when controlling for a past history of suicide attempt. No specific anxiety disorder was an independent predictor of time to attempt in this anxiety-disordered sample. Adding baseline physical health variables and social functioning did not improve the ability of the model to predict time to suicide attempt. CONCLUSIONS: Mood disorders and past history of suicide attempts are the most powerful predictors of a future suicide attempt in this sample of individuals, all of whom have an anxiety disorder.


Subject(s)
Anxiety Disorders/epidemiology , Depressive Disorder/epidemiology , Epilepsy/epidemiology , Pain/epidemiology , Suicide, Attempted/statistics & numerical data , Adult , Agoraphobia/epidemiology , Comorbidity , Depressive Disorder, Major/epidemiology , Employment/statistics & numerical data , Female , Humans , Linear Models , Longitudinal Studies , Male , Middle Aged , Panic Disorder/epidemiology , Phobic Disorders/epidemiology , Proportional Hazards Models , Prospective Studies , Risk Factors , Stress Disorders, Post-Traumatic/epidemiology , Suicide/statistics & numerical data
5.
Psychol Med ; 39(4): 591-601, 2009 Apr.
Article in English | MEDLINE | ID: mdl-18588740

ABSTRACT

BACKGROUND: Psychological literature and clinical lore suggest that there may be systematic differences in how various demographic groups experience depressive symptoms, particularly somatic symptoms. The aim of the current study was to use methods based on item response theory (IRT) to examine whether, when equating for levels of depression symptom severity, there are demographic differences in the likelihood of reporting DSM-IV depression symptoms. METHOD: We conducted a secondary analysis of a subset (n=13 753) of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) dataset, which includes a large epidemiological sample of English-speaking Americans. We compared data from women and men, Hispanics and non-Hispanic Whites, African Americans and Whites, Asian Americans and Whites, and American Indians and Whites. RESULTS: There were few differences overall, although the differences that we did find were primarily limited to somatic symptoms, and particularly appetite and weight disturbance. CONCLUSIONS: For the most part, individuals responded similarly to the criteria used to diagnose major depression across gender and across English-speaking racial and ethnic groups in the USA.


Subject(s)
Depressive Disorder, Major/ethnology , Diagnostic and Statistical Manual of Mental Disorders , Ethnicity/psychology , Adolescent , Adult , Aged , Aged, 80 and over , Cross-Sectional Studies , Depressive Disorder, Major/diagnosis , Depressive Disorder, Major/epidemiology , Depressive Disorder, Major/psychology , Female , Health Surveys , Humans , Male , Middle Aged , Psychometrics/statistics & numerical data , Reproducibility of Results , Sex Factors , United States , Young Adult
6.
Biol Psychiatry ; 46(2): 202-11, 1999 Jul 15.
Article in English | MEDLINE | ID: mdl-10418695

ABSTRACT

BACKGROUND: This study of a large clinical sample of depressed patients examined whether childhood onset as compared with adult onset Major Depressive Disorder (MDD) would confer a greater risk for Axis I comorbidity and whether childhood onset MDD would also differ from adult onset MDD in the pattern of comorbid disorders. METHODS: We examined lifetime co-occurrence of Axis I disorders among 381 adult outpatients with MDD by Structured Clinical Interview for DSM-III-R-Patient Edition (SCID-P). Subjects were divided into childhood onset (n = 47), adolescent onset (n = 101) and adult onset (n = 233) MDD groups. RESULTS: We found that the two early-onset groups exhibited significantly increased rates of Axis I comorbidity. The childhood onset group accounted for a disproportionately high percentage of depressed adults with two or more comorbid Axis I disorders. Social and simple phobias and alcohol abuse/dependence were significantly more prevalent among individuals with childhood onset MDD than among individuals with adult onset MDD. Alcohol abuse/dependence, but not anxiety disorders, was significantly more prevalent among adolescent onset than adult onset MDD groups. Panic, generalized anxiety, obsessive-compulsive and somatoform disorders were equally distributed across MDD onset groups. Comorbid disorders were much more likely to have followed onset of MDD among individuals with childhood compared with adult onset, except for social phobia which more frequently preceded the depression. The relative ordering among the comorbid conditions with respect to whether they followed or preceded MDD did not vary notably across the three age of onset groups. CONCLUSIONS: We conclude that early-onset MDD is associated with an increased density of Axis I comorbidity that seems to be limited to specific disorders.


Subject(s)
Alcoholism/complications , Depressive Disorder, Major/complications , Phobic Disorders/complications , Adult , Age Factors , Age of Onset , Aged , Alcoholism/diagnosis , Alcoholism/epidemiology , Comorbidity , Depressive Disorder, Major/diagnosis , Depressive Disorder, Major/epidemiology , Female , Humans , Male , Middle Aged , Phobic Disorders/diagnosis , Phobic Disorders/epidemiology , Psychiatric Status Rating Scales
7.
Biol Psychiatry ; 42(7): 568-76, 1997 Oct 01.
Article in English | MEDLINE | ID: mdl-9376453

ABSTRACT

The purpose of this study was to investigate the relationships between depressive subtypes and response to fluoxetine treatment in a large cohort of outpatients. We studied 294 outpatients with major depressive disorder who were then treated with fluoxetine 20 mg/day for 8 weeks. Treatment outcome was evaluated with the Hamilton Depression Rating Scale (HDRS)-17, the Clinical Global Impressions-Severity, and with the HDRS-8; the latter is proposed to be a relatively more specific measure of depression severity than the HDRS-17. We assessed the relationships between degree of treatment response and several depressive subtypes (melancholic, atypical, hostile, and anxious depression, double depression, and depression with comorbid personality disorders), after adjusting for baseline depression severity. We found that nonanxious depressives (patients without any comorbid anxiety disorder) improved slightly but significantly more during treatment than anxious depressives on all outcome measures. Melancholic depression was associated with slightly less improvement on the HDRS-17 only, whereas the other subtypes of depression were not associated with differences in treatment outcome.


Subject(s)
Antidepressive Agents, Second-Generation/therapeutic use , Depressive Disorder/psychology , Depressive Disorder/therapy , Fluoxetine/therapeutic use , Adolescent , Adult , Aged , Anxiety/complications , Depressive Disorder/classification , Female , Humans , Male , Middle Aged , Psychiatric Status Rating Scales
8.
Psychol Med ; 27(3): 627-33, 1997 May.
Article in English | MEDLINE | ID: mdl-9153683

ABSTRACT

BACKGROUND: Increasing attention has been directed in recent years to the detection and treatment of psychiatric co-morbidity among depressed individuals. The overlap of social phobia (SP) and avoidant personality disorder (APD) has been well recognized and a relationship between these disorders and depression has been suggested. METHODS: The pattern and clinical implications of co-morbidity of SP and APD with major depressive disorder (MDD), diagnosed by DSM-III-R criteria, were studied among 243 out-patients presenting with depression. RESULTS: Overall, 26.7% of adults in our sample with MDD met criteria for SP and 28.4% for APD. Almost two-thirds of depressed adults meeting criteria for social phobia or avoidant personality disorder met criteria for both (SP+APD). Depressed adults who met criteria for both SP+APD exhibited a significantly higher proportion of atypical depression (54.8%) compared with those with neither SP nor APD (31.1%). Among depressed patients, the co-occurrence of SP with APD was also associated with an earlier age of onset of MDD, a greater number of comorbid Axis I diagnoses, and greater impairment of social adjustment and assertiveness. CONCLUSIONS: Results confirm the overlap of SP and APD in a depressed population and the high prevalence of these disorders in MDD. They suggest that depressed individuals with both SP and APD but not SP alone are at particularly high risk for atypical depression and for social dysfunction in excess of that caused by a current major depression.


Subject(s)
Depressive Disorder/epidemiology , Personality Disorders/epidemiology , Phobic Disorders/epidemiology , Social Behavior Disorders/epidemiology , Adult , Analysis of Variance , Chi-Square Distribution , Comorbidity , Cross-Sectional Studies , Female , Humans , Male , Massachusetts/epidemiology , Middle Aged , Prevalence , Social Adjustment
10.
Psychother Psychosom ; 63(3-4): 207-11, 1995.
Article in English | MEDLINE | ID: mdl-7624468

ABSTRACT

One hundred forty-eight patients, ages 18-65, with major depression were administered the Mini-Mental State Examination (MMSE) prior to 8 weeks of treatment with fluoxetine; 75 of these patients were readministered the MMSE following treatment. MMSE scores were not related to pretreatment severity of depression or to reported concentration problems and were not predictive of antidepressant response. Non- and partial responders had lower posttreatment MMSE scores than responders, men had lower posttreatment scores than women, and subjects over 50 had lower pretreatment scores than younger subjects, although in all cases, the magnitude of the differences was small and unlikely to be clinically important. Our results suggest that while the MMSE has been shown to be useful among geriatric and other depressed inpatients, it is not a sensitive indicator of depression severity, concentration problems, or likelihood of treatment response among otherwise healthy adults with major depression in an outpatient setting.


Subject(s)
Depressive Disorder/psychology , Mental Status Schedule/statistics & numerical data , Adolescent , Adult , Aged , Ambulatory Care , Depressive Disorder/diagnosis , Depressive Disorder/drug therapy , Double-Blind Method , Female , Fluoxetine/adverse effects , Fluoxetine/therapeutic use , Follow-Up Studies , Humans , Male , Middle Aged , Personality Inventory/statistics & numerical data , Psychometrics
SELECTION OF CITATIONS
SEARCH DETAIL
...